The Intellectual Property Review - 7th Edition

The Intellectual Property Review - 7th Edition

Pages: 368

ISBN: 978-1-910813-60-7

  • £350.00

To aid practitioners who are navigating this ever-changing landscape of global intellectual property, we now present the seventh edition of The Intellectual Property Review.

In this edition, we present an overview of forms of the intellectual property coverage available in 25 jurisdictions along with an update of its most recent developments.

In this book: 


  • Preface
    • Dominick A Conde, Fitzpatrick, Cella, Harper & Scinto
  • Upcoming Changes to European Patent Litigation
    • Peter Damerell, Richard Fawcett and Bryce Matthewson, Powell Gilbert LLP


  • Belgium
  • Brazil
  • Canada
  • Chile
  • China
  • Cyprus
  • Denmark
  • France
  • Greece
  • India
  • Israel
  • Japan
  • Korea
  • Luxembourg
  • Malta
  • Mexico
  • Netherlands
  • Philippines
  • Portugal
  • Russia
  • Switzerland
  • Taiwan
  • United Kingdom
  • United States
  • Vietnam

Dominick A Conde, Fitzpatrick, Cella, Harper & Scinto

Dominick Conde is a partner at Fitzpatrick, Cella, Harper & Scinto and is widely recognised for his experience and accomplishments in patent litigation. For almost 30 years, Mr Conde has tried and argued patent cases, including arguing numerous cases before the Court of Appeals for the Federal Circuit, and United States District Courts. He is active in all aspects of the firm’s patent practice, focusing particularly on large-scale litigation matters related to chemistry, pharmaceuticals and pharmaceutical devices and diagnostics. He has appeared and been lead counsel for numerous major international companies including Astellas Pharma, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly & Co, Entegris, LEO Pharma, Merck & Co., Pfizer, Reckitt-Benckiser, Reliable Sprinkler Company, Sanofi-Aventis, Novartis, Aralez Pharmaceuticals, Pernix Therapeutics and Warner Chilcott.

Mr Conde has been widely recognised by many publications as a leader in the life sciences field. He has been recognised as a leading patent lawyer by Chambers (2011 to present); recognised as a top intellectual property law practitioner by Best Lawyers in America (2011, 2014, 2015, 2016); recognised as a leading patent litigator by Legal 500 (2008, 2009, 2011, 2012, 2014); named a Leading Lawyer, LMG Life Sciences (2012–14); named a Top 10 Life Science Litigator, Managing Intellectual Property (2013–15); named an IP Star, Managing Intellectual Property (2013–15); and in 2015 received the Burton Award for writing an article in New York Law Journal. Clients have also recognised his skills, talent and expertise: ‘He sees the forest through the trees and never gets tunnel vision. He also understands the need to find business solutions to legal problems and is very pragmatic.’(IAM Patent 1000: The World’s Leading Patent Practitioners 2015); ‘an intellectual giant, but one who can distill complex patent issues into clear, concise and cogent language that anyone can understand. Business leaders like him because of his clarity. Attorneys like him because they know his direct advice is grounded in thorough legal analysis and experience’ (Best Lawyers 2014); ‘completely stands out in terms of raw intelligence, lawyering skills and putting together the perfect case’ (Chambers USA 2013); and ‘superb litigator’ (IAM Patent 1000 The World’s Leading Patent Practitioners 2013); ‘the best trial lawyer in the country for complex medical cases’ (Legal 500 2012); ‘an outstanding strategist and litigator. If you end up going to trial, he is amazing – nothing gets by him.’ (Legal 500 2011).

Mr Conde formerly served as the firm’s managing partner and is currently on the firm’s management committee.

We Also Recommend